Example report. The whole genome example: a public genome from the 1000 Genomes Project, with CYP2D6 Structural Analysis, so you can see what yours will look like. Get your own report

Pain managementExample report

Pitolisant

Wakix

Use as directed

Your body processes this drug faster than average. The FDA gives no dose change for your result, so the usual dose is used.

The genes behind this label

The guidelines read one gene for pitolisant. Each card shows the two copies this person inherited and what they mean.

CYP2D6*2/*2x2

Ultrarapid metabolizer

One copy works normally and one works faster than usual.

3.0 activity scoreTypical: 1.25 to 2.25

Turns on or clears about 1 in 4 prescription drugs. These include many drugs for depression, pain and ADHD.

This result doesn't change the label.

What the guidelines say

What each guideline says about your result.

CYP2D6Ultrarapid metabolizer

FDA drug label

See the FDA table (U.S. Food and Drug Administration, opens in a new tab)

In plain words: Your body processes this drug faster than average. The FDA gives no dose change for your result, so the usual dose is used.
What it means: No FDA guidance for this phenotype
What the label suggests: Initiate therapy with recommended starting dose.

About pitolisant

Pitolisant (Wakix) treats excessive daytime sleepiness and cataplexy in people 6 and older with narcolepsy.

Used for: Excessive daytime sleepiness or cataplexy in people 6 and older with narcolepsy

Others in pain management

Compare all 13 pain management

And 4 more

Don't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.

Back to the example report